Brazilian society of hepatology updated recommendations for systemic treatment of hepatocellular carcinoma
| dc.creator | Aline Lopes Chagas | |
| dc.creator | Mariana Fonseca Dotori | |
| dc.creator | Rosangela Teixeira | |
| dc.creator | Carlos Eduardo Brandão Melo | |
| dc.creator | Cassia Regina Guedes Leal | |
| dc.creator | Vivianne Barreto de Mello | |
| dc.creator | Fábio Marinho do Rego Barros | |
| dc.creator | Paulo Lisboa Bittencourt | |
| dc.creator | Angelo a Mattos | |
| dc.creator | Dayse Aroucha | |
| dc.creator | Leonardo g da Fonseca | |
| dc.creator | Joyce Roma Lucas de Silva | |
| dc.date.accessioned | 2025-07-25T20:06:34Z | |
| dc.date.accessioned | 2025-09-09T00:59:56Z | |
| dc.date.available | 2025-07-25T20:06:34Z | |
| dc.date.issued | 2020 | |
| dc.format.mimetype | ||
| dc.identifier.doi | https://doi.org/10.1590/S0004-2803.202000000-20 | |
| dc.identifier.issn | 16784219 | |
| dc.identifier.uri | https://hdl.handle.net/1843/83852 | |
| dc.language | eng | |
| dc.publisher | Universidade Federal de Minas Gerais | |
| dc.relation.ispartof | Arquivos de Gastroenterologia | |
| dc.rights | Acesso Aberto | |
| dc.subject | Liver Neoplasms | |
| dc.subject | Societies, Medical | |
| dc.subject.other | Hepatocelullar carcinoma, diagnosis | |
| dc.subject.other | Hepatocelullar carcinoma, therapy. | |
| dc.subject.other | Liver Neoplasms | |
| dc.subject.other | Societies, Medical | |
| dc.subject.other | Brazil | |
| dc.title | Brazilian society of hepatology updated recommendations for systemic treatment of hepatocellular carcinoma | |
| dc.type | Artigo de periódico | |
| local.citation.epage | 20 | |
| local.citation.issue | Suplemento 1 | |
| local.citation.spage | 1 | |
| local.citation.volume | 57 | |
| local.description.resumo | Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. The Brazilian Society of Hepatology (SBH) published in 2015 its first recommendations about the management of HCC. Since then, new data have emerged in the literature, prompting the governing board of SBH to sponsor a single-topic meeting in August 2018 in São Paulo. All the invited experts were asked to make a systematic review of the literature reviewing the management of HCC in subjects with cirrhosis. After the meeting, all panelists gathered together for the discussion of the topics and the elaboration of updated recommendations. The text was subsequently submitted for suggestions and approval of all members of the Brazilian Society of Hepatology through its homepage. The present manuscript is the final version of the reviewed manuscript containing the recommendations of SBH. | |
| local.publisher.country | Brasil | |
| local.publisher.department | MED - DEPARTAMENTO DE CLÍNICA MÉDICA | |
| local.publisher.initials | UFMG | |
| local.url.externa | https://www.scielo.br/j/ag/a/jnWVcf9QdnNQNgsYQ8KxjBk/?lang=en |